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Abstract 
This study addresses the impact of healthcare spending on quality of health. Particularly, it 
investigates the impact of health budget allocation, health system performance, a nation’s 
income, and demographic aspects on prompting health quality across the MENA region. The 
yearly data sample used covers the period 1995–2016. The estimated model is tested using the 
appropriate GLS random effects method. The findings do not show support for public spending 
on healthcare to improve healthcare quality across the MENA region. However, higher private 
spending on healthcare leads to lower infant mortality rates, thus improving healthcare quality. 
The results also show that the improvement in income per-capita for oil-exporting countries 
leads to improved quality of healthcare as well as in non-oil-exporting countries, however the 
marginal benefit is lower for oil-exporting countries, compared to non-oil-exporting countries. 
This might suggest that oil-exporting countries have already reached a significant floor level 
of infant mortality rate that cannot be improved. However, non-oil-exporting countries still 
have potential to reduce the infant mortality rate and improve the quality of healthcare. 
Keywords: Health Quality, Budget Allocation, Oil Exporters, MENA 
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I. Introduction 
The level of economic and social 
development is a key for the government to 
spend on different economic sectors. 
Addressing the issue of budget allocation 
within the health sector is very important 
for low-income, developing countries. This 
is as the rapid growth of spending on health 
attracts more attention by household, 
businesses, and government. However, the 
issue might be not so different for certain 
high-income countries, especially in the 
Middle East and North Africa (MENA) 
region.  
 
The justification of higher health spending 
for better healthcare quality is that more 
spending leads to better allocation of 
economic resources, which leads to better 
health outcomes (i.e. Ali, Ismatullah, and 
Ashghar, 2017; Anand and Ravallion, 
1993; Bakare, and Olubokun, 2011, Bedir, 
2016; Churchill, Yew, and Ugur, 2015; 
Hojman, 1996; and Serdar, 2015). 
Investigating the impact of health spending 
on health quality is very important. 
Although there is a large amount of 
literature studying the impact of health 
expenditure on healthcare quality (Anand 
and Ravallion, 1993; Hojman, 1996; 
Filmer, Hammer and Pritchett, 1998; 
Ravallion and Bidani, 1999; Gupta, 
Verhoeven and Tiogson, 2002; Mendis and 
Ichihashi, 2014), there is limited literature 
regarding developing countries, especially 
in the MENA region. Thus, this paper 
contributes to the literature by studying the 
case of the MENA region. In addition, this 
study shows the difference in health 
expenditure between public and private 
sectors, according to health funding 
mechanisms, and thus investigates the 
impact of public and private healthcare 
expenditure on health quality for the 
MENA region. This paper also makes a 
distinction between oil-exporting countries 
and non-oil-exporting countries across the 
MENA region. This study shows the 
different impact of healthcare expenditure 
on health quality between oil-exporting and 
non-oil-exporting countries. This paper is 
not in a position to determine or conclude 
what may be the main drivers of healthcare 
quality. However, it provides key 
considerations for future plans and 
strategies, in light of these findings, for 
shaping a better, coherent system. 
Filmer et al. (1998) investigated the 
influence of public spending on health. 
However, their key finding was not clear. 
Others, such as Baltagi and Moscone 
(2010), examined the economic link 
between health spending and income across 
the Organization for Economic Co-
operation and Development (OECD) 
countries. They found the relationship 
between health spending and income to 
exist in the long run. The link between 
spending in healthcare and economic 
growth was examined by Ndedi, Metha, 
and Nisabwe (2017). They found that more 
health expenditure promotes economic 
growth. Accordingly, this study attempts to 
extend the literature to investigate the 
relationship between spending on 
healthcare and healthcare quality. This 
paper seeks to reassess the case of the 
MENA region by using different 
specifications, such as private versus public 
health expenditure and oil exporting 
countries versus non-oil exporting 
countries, across the MENA region.  
This paper uses yearly data samples from 
1995–2016. The benchmark estimated 
model is tested using the GLS random 
effects method. The findings confirm that 
higher private spending on healthcare leads 
to a better quality of healthcare. However, 
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the findings show no significant result for 
public spending on healthcare influencing 
healthcare quality across the MENA region. 
Specifically, the higher the income per 
capita, the higher quality of healthcare for 
oil-exporting countries as well as non-oil-
exporting countries; however, the marginal 
benefit of spending on healthcare was 
found to be lower for oil-exporting 
countries, compared to non-oil-exporting 
countries. 
The remainder of this paper is organized as 
follows. Section II is a review of the 
relevant literature. After that, the paper 
provides an overview of the health sector 
environment in the MENA region. Then the 
methodology and data are described in 
Section IV. The empirical results are 
presented, and, finally, conclusions and 
some policy recommendations are provided 
in Section VII. 
II. Literature Review 
Economists have tried to empirically link 
the effect of public budget allocations to 
healthcare outcomes (i.e. Fosu, 2008). 
Mendis and Ichihashi (2014) investigated 
the influence of Sri Lanka’s government 
expenditure on healthcare development. 
Their findings suggested that government 
spending has an influence on infant 
mortality rates. A study by Rajkumar and 
Swaroop (2008) investigated the impact of 
government spending along with health 
determinates on healthcare outcomes across 
27 countries. The results showed that public 
health spending and per-capita income have 
a negative effect on child mortality rates. 
However, their paper showed that, as the 
level of corruption falls, public spending on 
health becomes more effective on lowering 
child mortality. A study by Ravallion and 
Bidani (1999) investigated the impact of 
public spending on the health status. They 
found that spending stimulates health 
outcomes across 35 countries. Of the 
countries they studied, only Algeria, 
Jordan, and Tunisia were are in the MENA 
region. 
Another study by Gupta et al. (2002) 
examined the effectiveness of public 
expenditure on healthcare outcomes across 
50 developing and transitioning countries. 
Their findings supported other studies in 
which public spending had a negative 
relationship with mortality rates. However, 
a study by Filmer et al. (1998) failed to find 
a statistically significant influence of public 
healthcare spending on infant mortality 
rates. There have been many studies that 
have found a link between spending more 
on healthcare and better health outcomes. 
These include Anand and Ravallion (1993) 
and Hojman (1996). On the other hand, 
Cima and Almeida (2018) analyzed the 
dynamics of GDP and health expenditure 
for 25 OECD countries from 1993–2015. 
They concluded that health status is caused 
by GDP growth rather than by health 
spending growth. These results showed that 
countries mostly financed by compulsory 
health insurance schemed had a worse 
health status, even though there was no 
decrease in the growth of health 
expenditure. 
The determinants of health expenditure 
may vary according to the size of the 
economy. Yazdi and Khanalizadeh (2017) 
examined the role of economic growth and 
the quality of the environment as the 
determining factors for health expenditure 
in the MENA region. The study concluded 
that environmental quality has a statistically 
significant impact on health expenditure. 
Wang and Lee (2018) investigated the role 
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of another determinant of health 
expenditure, in the context of economic 
growth. They tested the impact of life 
insurance on health expenditure and 
economic growth. The conclusion was 
summarized in two different scenarios. If 
the life insurance scheme in an economy is 
low, the decrease in life insurance can 
stimulate health expenditure as well as 
economic growth. If life insurance is on the 
rise, there is no significant impact of life 
insurance health expenditure and economic 
growth. 
Cooray (2013) divided data into two 
categories and explored the effect of health 
capital on economic growth. First, the data 
was segregated by gender and revealed that 
health capital does not have a significant 
and robust impact on economic growth. 
Second, the data was segregated by income 
level and revealed that the effect of health 
capital on economic growth was 
statistically significant in higher- and 
upper-middle-income economies. In low-
income economies, the impact of health 
capital on economic growth is significant 
only if engaged in education. 
Many studies have investigated the case of 
MENA region (i.e. Mehrara, Akbar, Abbas, 
Reza, 2012; Sadr, and Gudarzi, 2013; and 
Verhoeven, Gupta, and Tiongson, 1999).  
Importantly Verhoeven, Gupta, and 
Tiongson, 1999 used a sample of 50 
developing and transitioning countries to 
show that expenditure allocations reduced 
mortality rates for infants and children. 
Some of the 50 countries in Verhoeven et 
al. (1999) were in the MENA region, such 
as Jordan, Tunisia, Egypt, and Morocco. 
The main result of that study was that there 
is little empirical evidence to support the 
claim that public spending improves 
education and health indicators. 
Schultz (1993) estimated the effect of state 
public health spending in India on mortality 
across all age groups. The study showed 
that a 10% increase in public spending on 
health decreases the average probability of 
death by about 2%, which affects mainly 
the young, the elderly, and women. Other 
major factors affecting mortality are rural 
residency, household poverty, and access to 
toilet facilities. 
Swift (2011) examined the relationship 
between health and gross domestic product 
(GDP) for 13 OECD countries over the last 
two centuries. A long-run relationship 
between life expectancy and GDP per-
capita was found for all countries. The 
results showed that a 1% increase in life 
expectancy will result in a 5% increase in 
GDP per capita. In addition, total GDP and 
GDP per-capita also had a significant 
influence on life expectancy for most 
countries. 
According to previous studies, higher 
spending on healthcare leads to better 
quality of healthcare (Anand and Ravallion, 
1993; Hojman, 1996). Studies have also 
pointed out the effect of other control 
variables on healthcare quality. Better 
immunization against measles, as a result of 
improved children’s immunization 
coverage, may lead to better health quality 
(Hojman, 1996). Higher life expectancy 
rates in a community indicate lower 
mortality rates. Better economic resource 
allocation leads to improvements in total 
health status. This is because quality of 
health is improved as a result of increasing 
individual incomes (Ke, Saksena, and 
Holly, 2011). Studies also find that 
increases in urbanization lead to better 
healthcare quality (Schultz, 1993; 
Verhoeven et al., 1999). This is because 
infant mortality rates rise in rural areas as 
well as low-income household regions.  
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III. The Evolution of Health across 
MENA Region 
Development of the public health status 
across the MENA region shows that life 
expectancy at birth has been enhanced 
among all MENA countries over the last 
two decades. As shown in Figure A1, the 
average life expectancy across MENA 
countries increased from 68 years in 1995 
to 73 years in 2015, which is higher than the 
world average life expectancy.1 Table A1 
compares life expectancy for each country 
in 1995 and 2015. Malta, Qatar, and 
Lebanon had the highest life expectancy 
among all MENA countries, which reached 
to 82, 79, and 79 years, respectively, in 
2015, compared to 77, 76, and 72 years, 
respectively, in 1995. Djibouti and Yemen 
recorded the lowest life expectancy among 
all MENA countries, which reached 62 and 
64 years, respectively, in 2015, compared to 
57 and 58 years, respectively, in 1995. The 
figures shown in Table A1 demonstrate that 
life expectancy for women in all MENA 
countries was higher than that of men in 
both years. 
MENA countries have made considerable 
improvements over the last 20 years with 
respect to the average infant mortality rate. 
Figure A2 shows that the average infant 
mortality rate across MENA countries 
decreased by 50% in 2015, to reach 20.6 
deaths per 1,000 live births, compared to 
41.6 deaths per 1,000 live births in 1995.2 
In addition, Table A2 presents country-
specific data for the MENA region for some 
health indicators: infant mortality per 1,000 
live births, under-5-years child mortality 
per 1,000 live births, and children’s 
                                                            
1 The average world life expectancy was 66 years 
in 1995 and 72 years in 2015. 
immunization against measles as a 
percentage of children aged 12–23 months. 
Malta, the United Arab Emirates (UAE), 
and Kuwait had the lowest infant and 
under-5-years child mortality rates in 1995, 
about 8, 9, 11, 13, and 13, 15 per 1,000 live 
births for both indicators, respectively. 
However, the picture of the progress made 
by other MENA countries to reduce both 
the infant and under-5-years child mortality 
rates had changed by 2015. Six countries 
were found to have deaths less than 10 per 
1,000 live births. Malta had 5 and 7 deaths 
per 1,000 live births in infants and children 
under 5-years old, respectively. Bahrain 
and UAE had 6 infant deaths per 1,000 live 
births and 7 under-5-years deaths per 1,000 
live births. Infant and under-5-years child 
mortality rates in Qatar, Lebanon, and 
Kuwait reached 7,8, 7,9, and 8,9 per 1,000 
live births, respectively. All MENA 
countries, except Djibouti, Lebanon, and 
Yemen, achieved higher levels of measles 
immunization that covered more than 93% 
of children in 2015.  
Figure A3 shows that the average total 
health expenditure (ATHE) as a percentage 
of GDP across MENA countries slightly 
increased, from 4.2% in 1995 to 5.4% in 
2015. The MENA region’s ATHE is 
considered relatively low, compared to 
some other regions. For instance, the 
world’s ATHE was 9.9% in 2015, whereas 
in Euro Area, it was 10.2%. Latin America, 
the Caribbean and OCED recorded 7.4% 
and 12.5%, respectively. However, the 
MENA region’s ATHE was equal to that of 
Sub-Saharan and higher than that of South 
Asia, which was 3.7% in in 2015. 
Furthermore, the data in Table A3 shows 
2 The average world mortality rate was 60.5 and 
31.4 per 1,000 live births rate in 1995 and 2015, 
respectively. 
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that in 2015, public health expenditure as a 
share of government expenditure varied 
among MENA countries, with the highest 
value (18%) in Iran and the lowest value 
(4%) in Yemen. Over the period 1995–
2015, public health expenditure as a share 
of government expenditure increased for 
most MENA countries, except Bahrain, 
Egypt, Iran, UAE, and Yemen. Table A3 
also illustrates that governments finance a 
high proportion of health expenditure in 
most MENA countries.  
It is worth mentioning that public health 
expenditure as a percentage of total health 
expenditure reached 63–90% in all MENA 
countries in 2015, except for Egypt, Iran, 
Lebanon, Morocco, and Yemen. This high 
proportion explains the absence, or 
shrinking role, of private-sector 
involvement in the healthcare market. 
Figures in Table A3 denote that the Gulf 
Cooperation Council (GCC) countries, as 
high-income countries, had the highest 
health expenditure per capita among 
MENA countries in 2015. In Qatar, health 
expenditure per capita reached 2,106$, 
1,243$ in Bahrain, 1,611$ in UAE, 1,386$ 
in Kuwait, and 1,147$ in Saudi Arabia. 
Despite these high values, MENA 
countries’ average health expenditures per 
capita in 2015 (415$) was below the world 
average of 1,002$, Euro Area (3,487$), 
OECD (4,526$), and Latin America and the 
Caribbean (636$) but were higher than that 
of South Asia (58$) and sub-Saharan (84$).  
IV. Methodology 
This study empirically examines the impact 
of healthcare expenditure on the quality of 
health across MENA countries. In specific, 
the objective of this paper is to examine the 
impact of health expenditure, immunization 
against measles, life expectancy, per-capita 
income, and urbanization on health quality. 
The study employs panel techniques by 
using pooled OLS, fixed effects and 
random effects. Using the fixed effects 
approach helps isolate any variations across 
individuals, while the random effects 
approach is better used by allowing 
variations across individuals (Kreft and De 
Leeuw, 1998, and Seddighi, and Lawler, 
2000). Specifically, estimation using the 
generalized least squares (GLS) random 
effects regression allows time-invariant 
factors (such as time-invariant dummy 
variables) to be efficiently tested and 
estimated as explanatory variables. Also, 
GLS allows the maximum likelihood 
estimate coefficients at what time the 
residual term is of unequal variance 
(Aitken, 1936). Accordingly, the Hausman 
test is applied to choose the appropriate 
estimating model between fixed effects and 
random effects. Several tests are then 
applied to expand the findings and reach a 
better understanding of health quality 
determinants across the MENA region. 
The choice of the explanatory variables 
affecting the quality of healthcare relies on 
different aspects (Newhouse, 1977, and 
Verhoeven et al., 1999). These factors 
include health budget allocation, health 
system performance, the nation’s income, 
and demographics. Health budget 
allocation represents how much of its 
budget the country devotes to healthcare 
(Anand and Ravallion, 1993; Schultz, 1993; 
Hojman, 1996; Gupta et al., 2002; Ke et al., 
2011; Mendis and Ichihashi, 2014; and 
Rhee, 2014). Theoretically, higher 
spending on health leads to a higher quality 
of healthcare in a country. This effect can 
be captured through the variable of 
healthcare expenditure. In addition, the 
importance of the health system depends on 
the performance factors that reflect the 
efficiency of healthcare services in the 
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country. Therefore, indicators of health 
performance may be good signs of the 
healthcare status of the country. These 
indicators can include the independent 
variables life expectancy and 
immunization. In addition, controlling for 
the income in the country relies on the fact 
that identities of government and household 
sectors depend heavily on the capacity of 
country’s wealth and income. This is 
because high-income countries allocate a 
higher budget share to healthcare spending 
than low-income countries. The 
independent variable that captures this is 
per-capita GDP. Finally, the demographic 
factor ,which is controlled by urbanization, 
suggests that unplanned urbanization is 
frequently related with limited healthcare. 
This is because people’s needs in these 
areas exceed the healthcare service capacity 
of the country. Therefore, it is expected that 
higher urbanization leads to higher 
healthcare quality. The following equation 
represents the main determinants of 
healthcare quality: 
ሺܪ݈݁ܽݐ݄	ܳݑ݈ܽ݅ݐݕሻ௜௧ ൌ
	݂	ሺ	ܤݑ݀݃݁ݐ, ܪ݈݁ܽݐ݄	ܵݕݏݐ݁݉,
	ܫ݊ܿ݋݉݁,ܦ݁݉݋݃ݎܽ݌݄ݕሻ ௜௧   (1) 
where Health Quality indicates the 
healthcare quality for country i at time t. 
The control factors include budget 
allocation that is represented expenditure 
on health, indicators of healthcare include 
expectancy life rate and immunization, 
income is represented by the level of GDP 
per capita in the country, finally 
demographic factor which is represented by 
urban population.  
Accordingly, the reduced form of the 
estimated model closely follows the work 
of Verhoeven et al. (1999) and can be 
expressed as the following: 
ሺܪ݈݁ܽݐ݄	ܳݑ݈ܽ݅ݐݕሻ	௜௧ = ∝ + 
ߚଵሺܧݔ݌݁݊݀݅ݑݎ݁ሻ௜௧ + 
ߚଶሺܫ݉݉ݑ݊݅ݖܽݐ݅݋݊ሻ௜௧ + 
ߚଷሺܮ݂݅݁	ܧݔ݌݁ܿݐܽ݊ܿݕሻ	௜௧ + ߚସሺܲܥ	ܩܦܲሻ௜௧ 
+ ߚହሺܷݎܾܽ݊݅ݖܽݐ݅݋݊	ሻ௜௧+ ߝ௜௧             (2) 
where Health Quality is the dependent 
variable measured by infant mortality per 
1,000 live births. Expenditure is measured 
by the share of total health expenditure to 
GDP. Immunization is measured by the 
measles immunization of children. Life 
Expectancy indicates the life expectancy of 
both males and females. ܲܥ	ܩܦܲ indicates 
per-capita GDP. Urbanization represents 
the share of the urban population to total 
population; i indicates the country, and t 
represents the time period. 
This study covers previous work by 
extending the estimated model to include a 
sample of countries in the MENA region. 
The estimated model also separates the test 
for oil-exporting versus non-oil-exporting 
countries in the MENA region, to analyze 
the influence of health expenditure on 
healthcare quality. Furthermore, the impact 
of health expenditure is classified into 
private versus public spending, which is 
then examined to see how the different 
spending affects health status. 
V. Data Description 
In this study, the annual data used is mainly 
obtained from the World Bank database, 
and the missing economic data is obtained 
from the IMF database. Some of the 
missing data obtained from IMF include the 
exchange rates to convert local currency 
data to US dollar.. The data covers the 
period from 1995–2016 for 20 selected 
countries in the MENA region. The 
selection of countries was based on data 
availability in the MENA region, taking 
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into consideration different income 
distributions across these countries. It is 
noteworthy that data availability limits 
adding more control variables, especially 
for the health data. As a result, the MENA 
countries are Algeria, Bahrain, Djibouti, 
Egypt, Iran, Iraq, Israel, Jordan, Kuwait, 
Lebanon, Libya, Malta, Morocco, Oman, 
Qatar, Saudi Arabia, Syrian, Tunisia, UAE, 
and Yemen.  
The under-5-years mortality rate is the 
likelihood per 1,000 live births that a child 
will die earlier than age five. All health 
expenditure variables are expenditure on 
health from domestic sources as a 
percentage of the economy, as measured by 
GDP. Child immunization is the ratio of 
children ages 12–23 months who received 
the measles vaccination prior to being 12-
months old. Life expectancy measures the 
years that a newborn infant may be alive at 
the time of its birth were to stay the same 
during its life. Finally, urbanization 
measures the urban population as a 
percentage of total population living in 
zones where the elevation is 5 meters or 
less. 
VI. Empirical Results 
Table A4 shows the summary statistics for 
the variables used in the study. Table B1 
shows the benchmark findings for all 
variables in the estimated model, using 
pooled OLS, fixed effects, and GLS 
random effects models.  
According to findings of the pooled OLS 
method, in column 1 of Table B1, only 
three variables are statistically significant 
and are consistent with other studies. The 
findings show that the estimated coefficient 
for measles immunization in children tends 
to be negative and statistically significant at 
a 1% level of significance. This suggests 
that higher rates of measles immunization 
lead to 0.137% lower infant mortality rates, 
which reflects a better quality of healthcare. 
The life expectancy variable’s estimated 
coefficient is statistically significant at a 
1% level of significance, with a negative 
sign. This indicates that higher life 
expectancy leads to a lower infant mortality 
rate, reflecting improved quality of 
healthcare, by 2.50%. In addition, the 
results show that higher per-capita income 
across the MENA region leads to better 
healthcare. The estimated coefficient for 
per-capita GDP tends out to be negative and 
statistically significant at a 1% level of 
significance. This suggests that higher per-
capita income leads to a lower infant 
mortality rate, by 0.026%, indicating a 
marginal improvement in the quality of 
healthcare.  
However, there is no evidence that higher 
spending on healthcare in the MENA 
region leads to lower infant mortality rates. 
Further investigation is carried out in the 
extended regressions in columns 2 and 3 of 
Table B1. The findings of all estimated 
coefficients in column 2 are statistically 
significant and consistent with their 
expected signs. The findings in column 3 
show that all estimated coefficients are 
statistically significant, with their expected 
signs, with the exception of urbanization, 
which is insignificant.  
In Table B2, the Hausman test showed that 
Prob>Chi2=0.9892, which is more than 
0.05. This confirms the use of the random 
effects technique. As a result, the 
justification of the main findings should 
rely on the results from the random effects 
model, to more precisely interpret the 
coefficients. 
In more specification testing in Table B3, 
The Breusch-Pagan Lagrange Multiplier 
can help decide between a GLS random 
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effects regression and a Pooled OLS 
regression. According to Table B3, the 
Prob>Chi2=0.0000 is less than 5%. This 
suggests rejection of the null; therefore the 
random effects model is an appropriate 
method to use. 
Accordingly, the results of Table B1 can be 
further interpreted based on the findings of 
Table B2 and Table B3. The findings of 
estimation using the GLS Random effects 
model reveal that all estimated coefficients 
are statistically significant and consistent 
with other studies, with the exception of 
urbanization, which tends to be 
insignificant. In particular, the estimated 
coefficient of healthcare expenditure is 
statistically significant at a 1% level of 
significance, suggesting that an increase in 
spending on health by 5% leads to a 
decrease in the infant mortality rate by 3.18 
per 1,000 live births. The estimated 
coefficient for immunization suggests that 
5% higher measles immunization for 
children decreases the infant mortality rate 
by 0.42 per 1,000 live births. The estimated 
coefficient for life expectancy indicates that 
a 1% increase in life expectancy decreases 
the infant mortality rate by 2.25 per 1,000 
live births. Finally, findings for the per-
capita income variable show that improving 
per-capita income by 5% leads to a decrease 
in the infant mortality rate by 0.17 per 1,000 
live births. These results indicate that the 
benefits from spending in healthcare across 
the MENA region are significant enough to 
improve the quality of healthcare. 
In order to examine the effect of private 
healthcare expenditure on health quality 
versus public healthcare expenditure, Table 
B4 shows the findings of the estimated 
model using the GLS random effects 
method. The results show that, across the 
MENA region, private healthcare 
expenditure have a negative impact on 
infant mortality rates, meaning that higher 
healthcare expenditure by the private sector 
result in lower mortality rates, indicating 
better healthcare. The finding is highly 
significant at a 1% level of significance. It 
suggests that increasing private spending on 
health by 1% would decrease the infant 
mortality rate by 1.27 per 1,000 live births. 
Surprisingly, the finding shows no evidence 
of public healthcare expenditure 
influencing the quality of healthcare. That 
finding is statistically insignificant. This 
results in Table B4 indicate that the 
healthcare sector would benefit from 
reallocation of health resources to the 
private sector, as opposed to spending in the 
public sector. 
In Table B5, the estimated model is again 
tested, using a separate test on a sample of 
oil-exporting countries and non-oil-
exporting countries. This examination 
investigates the likelihood of being a 
wealthy country (in this case, an oil-
exporting country) versus a low-income 
country (in this case, a non-oil-exporting 
country) and how that will reflect on the 
healthcare performance of the country. The 
findings in Table B5 show evidence that, 
for oil-exporting countries, all variables are 
statistically significant, with the expected 
signs. Specifically, the estimated 
coefficient of healthcare expenditure is 
statistically significant at a 1% level of 
significance, indicating that a 5% increase 
in spending on health will lead to a decrease 
in the infant mortality rate by 3.6 per 1,000 
live births. For non-oil-exporting countries, 
the estimated coefficient of healthcare 
expenditure is also statistically significant 
at a 1% level of significance. The finding 
suggests that a 5% increase in spending on 
14          NAYEF N. ALSHAMMARI, WAEL M. ALSHUWAIEE AND IBRAHIM MIRZA    
   
SBE, Vol.22, No.1, 2019  ©Copyright 2019/College of Business and      
ISSN 1818-1228         Economics, Qatar University 
health would decrease the infant mortality 
rate by 4.9 per 1,000 live births. This 
indicates that the benefits from spending on 
healthcare has marginal potential for non-
oil-exporting countries, compared to oil-
exporting countries. This may be because 
non-oil-exporting countries, which are 
mostly low-income countries (compared to 
oil-exporting countries) have more 
potential to improve their quality of health 
by spending on healthcare services. 
Whereas oil-exporting countries may have 
reached a point of healthcare quality at 
which any more spending on healthcare 
will increase its quality, but at a 
diminishing rate. This takes into 
consideration that people of oil-exporting 
countries have more opportunities to get 
medical treatment abroad. 
Another interesting finding in Table B5 is 
about per-capita GDP. For oil-exporting 
countries, the findings show that improving 
per-capita income by 5% leads to a decrease 
in the infant mortality rate by 0.127 per 
1,000 live births. However, for non-oil-
exporting countries a 5% increase in per-
capita income would decrease the infant 
mortality rate by 0.387 per 1,000 live births. 
This slight difference of increasing per-
capita income on health quality between 
oil-exporting countries and non-oil-
exporting countries suggests that the 
marginal benefit of healthcare is expected 
to be relatively lower as income increases 
(oil-exporting countries) compared to non-
oil-exporting countries. An explanation 
may be that oil-exporting countries (which 
are considered wealthy) have already 
reached a significant floor level of infant 
mortality rate that cannot be improved; 
however, the case is different for non-oil-
exporting countries (which are considered 
low-income) because they still have 
potential to reduce the mortality rate and 
catch up with other, high-income 
economies. 
VII. Conclusions and Policy 
Recommendations 
The purpose of this study was to investigate 
factors affecting healthcare quality across 
large, selected countries in the MENA 
region. Accordingly, the study used annual 
sample data for the period 1995–2016. The 
estimated model used the pooled OLS, 
fixed effects, and GLS random effects 
models. According to the appropriate GLS 
random effects model, the findings indicate 
higher health spending, higher rates of 
immunization for measles, higher life 
expectancy, and higher per-capita income 
all lead to a lower infant mortality rate, 
which means improved healthcare quality 
across the MENA region. 
Interestingly, there is evidence that higher 
private spending on healthcare in the 
MENA region leads to lower infant 
mortality rates, meaning improved 
healthcare quality. Whereas, no evidence is 
found for the impact of public healthcare 
spending on the infant mortality rate. In 
addition, the results of this study confirm 
that improvement in per-capita income will 
improve healthcare quality across the 
MENA region. Specifically, results for non-
oil-exporting countries show that the 
improvement in per-capita income, leading 
to a lower infant mortality rate, is more 
significant than for oil-exporting countries. 
A key policy implication can be drawn from 
the main findings of this study. These 
findings can support policy makers in 
drawing up better future plans. Importantly, 
the implication is that improving and 
making serious effort toward efficiency 
may help effectively allocate resources, 
especially in oil-exporting countries. It 
might be the case that these countries need 
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to direct more-efficient spending toward the 
healthcare sector. In the meantime, non-oil 
exporting countries should maintain the 
development that has been achieved on 
universal healthcare coverage and ensure 
delivery of the basic health services that 
provide quality in practice. 
Without a doubt, obtaining a certain level of 
economic development leads to more 
spending on social services, such as health, 
but it does not mean a certain quality might 
be obtained in return. Therefore, if 
countries in the MENA region need to 
promote economic growth and 
development, their governments should pay 
more attention to improve expenditure 
allocation in the health sector. 
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Appendix A 
Figure A1: Average Life Expectancy at Birth across MENA Countries 
 
           Source: World Bank database 
 
Table A1: Life Expectancy at Birth across Selected MENA Countries (in years) 
Source: World Bank database 
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Ye
ars
 1995 2015 
Country Male Female Total Male Female Total 
Algeria 67 70 68 73 78 75 
Bahrain 73 75 74 76 78 77 
Djibouti 56 59 57 60 64 62 
Egypt 64 69 67 69 73 71 
Iran 68 69 69 74 77 75 
Jordan 70 72 71 72 76 74 
Kuwait 72 74 73 73 76 75 
Lebanon 71 74 72 79 82 79 
Malta 75 80 77 80 84 82 
Morocco 65 69 67 73 75 74 
Oman 68 72 70 75 79 77 
Qatar 75 77 76 77 80 79 
Saudi Arabia 69 73 71 73 76 74 
Tunisia 69 74 72 73 77 75 
UAE 72 74 73 76 79 78 
Yemen 58 61 58 63 65 64 
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Figure A2: Average Infant Mortality Rate across MENA Countries 
 Source: World Bank database 
 
Table A2: Health Indicators across Selected MENA Countries 
Source: World Bank database 
Figure A3: Average Total Health Expenditure (% of GDP) across MENA Countries 
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 1995 2015 
Country Mortali
ty rate, 
infant 
Mortality 
rate, under 
5 years 
Immuniz
ation 
(measles) 
Mortalit
y rate, 
infant 
Mortality 
rate, under 
5 years 
Immunizatio
n (measles) 
(% of 
children 
ages 12-23 
months) 
Algeria 37 43 89% 22 26 95%
Bahrain 16 18 95% 6 7 99%
Djibouti 86 110 41% 56 67 71%
Egypt 49 65 89% 21 25 93%
Iran 36 45 95% 14 16 99%
Jordan 26 32 92% 16 19 98% 
Kuwait 13 15 98% 7 9 93% 
Lebanon 22 26 85% 8 9 79% 
Malta 8 9 51% 5 7 98% 
Morocco 52 63 88% 25 29 99%
Oman 21 25 98% 10 12 99%
Qatar 31 15 87% 7 8 99%
Saudi Arabia 25 30 94% 13 15 98%
Tunisia 36 45 91% 13 15 98%
UAE 11 13 90% 6 7 94%
Yemen 80 112 40% 34 42 67% 
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 Source: World Bank database 
 
Table A3: Health Expenditure (HE) Across Selected MENA Countries 
 1995 2015 
Country Public 
Health 
Expenditure 
(% gov 
exp) 
Public 
Health 
Expenditure 
(% total 
HE)  
Health 
Expenditure 
per capita 
(USD) 
Public 
Health 
Expenditure 
(% gov 
exp)
Public 
Health 
Expenditure 
(% total 
HE)
Health 
Expenditure 
per capita 
(USD) 
Algeria 9 72 54 10 73 362
Bahrain 11 69 485 10 63 1243
Djibouti 6 60 30 14 64 191
Egypt 5 47 37 6 38 177
Iran 6 45 68 18 41 351
Jordan 15 63 132 14 70 359
Kuwait 6 83 619 6 86 1386
Lebanon 14 34 461 11 48 569
Malta 10 68 610 16 69 2470
Morocco 5 33 48 6 34 190
Oman 7 84 227 8 90 675
Qatar 5 63 602 6 86 2106
Saudi Arabia 4 53 221 8 75 1147
Tunisia 11 49 127 14 57 305
UAE 8 79 737 9 72 1611
Yemen 6 32 40 4 23 80
Source: World Bank database 
 
Table A4: Summary Statistics 
 Observation Mean Std. Dev. Minimum Maximum
Mortality Rate 420 22.36381 17.50209 3.2 86.2
Health Expenditure 392 5.155519 2.204962 1.8747 13.43731
Public Health 
Expenditure 
392 2.924081 1.267616 1.267616 6.750848 
Private Health 
Expenditure 
392 2.225966 1.464178 0.2911267 8.44557 
Immunization 420 88.25476 13.91688 21 99 
Life Expectancy 420 72.3981 5.248327 56.98146 82.15366
Log Per-capita GDP 414 8.714746 1.288106 5.627538 11.39149
Urbanization 440 73.76296 17.93477 23.76 99.317
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Appendix B 
Table B1: Benchmark Results 
Dependent Variable: 
Health Quality 
Pooled OLS Fixed 
Effects
GLS Random 
Effects 
Health Expenditure 0.1769933 
(0.1551384) 
-0.7257963***  
(0.2123502) 
-0.6367887 *** 
(0.1837365) 
Immunization -0.1371536 *** 
(0.0226906) 
-0.0751791*** 
(0.0293425) 
-.0846208 *** 
(0.0273022) 
Life Expectancy -2.577104*** 
(0.0905587)
-1.899666 *** 
(0.2390683)
-2.255107 *** 
(0.1694999)
Log Per-capita GDP -2.618209*** 
(0.5240777)
-3.301929 *** 
(0.7742987)
-3.464257*** 
(0.6834372)
Urbanization 0.0341137 
(0.0267281) 
-0.293039 * 
(0.1788341) 
0.0114894 
(0.0641918) 
    
Obs. 381 381 381 
Adjusted R2/Within R2 0.9245 0.7001 0.6963 
 
Table B2: Results Using the Hausman Test 
Dependent Variable 
Health Quality 
Fixed Effects Difference 
Health Expenditure -0.7257963 -0.0890076 
Immunization -0.0751791 0.0094417 
Life Expectancy -1.899666 0.3554402 
Log Per-capita GDP -3.301929  0.1623278     
Urbanization -0.293039   -0.3045284     
 
Chi2 (5) 0.57 
Prob>Chi2 0.9892 
 
Table B3: Breusch-Pagan Lagrange Multiplier Test for Random Effects 
Estimated Results Variance Standard Deviation 
Dependent Variable Health Quality 320.4025 17.89979 
E (country, time) 11.1779 3.343336 
U (country) 16.50229 4.062301 
Test: Var (u) =0 
Chi2 (1) 779.47 
Prob>Chi2 0.0000
 
Table B4: Extended Results–GLS Random Effects 
Dependent Variable: 
Health Quality 
Public Health Expenditure Private Health Expenditure 
Health Expenditure -.0476152 
(0.3382278)
-1.276061 *** 
( 0.2602997) 
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Immunization -0.1159696 *** 
(0.0280649)
-0.0910223 *** 
(0.0258091) 
Life Expectancy -2.324677 *** 
(0.1729904) 
-2.275175 *** 
(0.1686093) 
Log Per-Capita GDP -2.959822 *** 
(0.7024361)
-3.267584 *** 
(0.6648816) 
Urbanization -.0268782 
(0.0667452)
-0.0231248 
(0.064601) 
  
Obs 381 381 
Adjusted R2/Within R2 0.6825 0.7058 
Note: The table reports the standards error in parentheses 
          * Significant at 10%; ** significant at 5%; *** significant at 1% 
          Robust standard errors (White test) 
 
Table B5: Extended Results: Oil-exporting versus Non-oil exporting Countries using GLS 
Random Effects 
Dependent Variable: 
Health Quality 
Sample of 
Oil-exporting Countries
Sample of 
Non-oil-exporting Countries
Health Expenditure -0.7208167 *** 
(0.1698824)
-0.9575439 *** 
(0.2817913) 
Immunization -0.0928483 ***  
(0.0362772)
-0.015471   
(0.0368467) 
Life Expectancy -1.302155 *** 
(0.1691771) 
-2.191673 *** 
(0.2717035) 
Log Per-capita GDP -2.540255 ***   
  (0.4706346)
-7.733103 *** 
(1.358331) 
Urbanization  -0.1400902 **  
(0.0677416)
0.1267888   
(0.095197) 
  
Chi2 (5) 168 213
Prob>Chi2 0.8519 0.7299              
Note: The table reports the standards error in parentheses 
          *Significant at 10%; ** significant at 5%; *** significant at 1% 
          Robust standard errors (White test) 
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